Results 281 to 290 of about 226,308 (303)

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

New England Journal of Medicine, 2011
William E Boden, Koon K Teo
exaly  

Statins

Nephrology Times, 2012
openaire   +2 more sources

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

Lancet, The, 2010
Naveed Sattar, David Preiss, J Wouter Jukema   +2 more
exaly  

Statins

2021
openaire   +1 more source

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

Lancet, The, 2010
Paul M Ridker, Jacques Genest jr, S Matthijs Boekholdt   +2 more
exaly  

Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study

Lancet, The, 2013
Jonathan Myers, Demosthenes B Panagiotakos, Michalis Doumas   +2 more
exaly  

Statins

Nihon rinsho. Japanese journal of clinical medicine, 2007
openaire   +3 more sources

Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study

Lancet, The, 2007
John R Thompson, Nilesh J Samani
exaly  

Statins

Journal of Hypertension, 2002
van Dokkum, RPE, Henning, RH, de Zeeuw, D   +2 more
openaire   +1 more source

Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events

New England Journal of Medicine, 2001
Paul M Ridker
exaly